via AFAO/NAPWHA/Thorne Harbour Health, March 2021 Australia has now begun Phase 1b of the Covid-19 vaccination roll-out program. All people living with HIV are eligible to receive the vaccine during this phase. There is an Covid Vaccine Eligibility declaration form that Phase 1B eligible patients can take with them to any vaccination clinic / hub. HIV positive patients are explicitly included...
Various sources, March 2020 RANZCOG statement: A message for pregnant women and their families The Lancet Study on COVID-19 Transmission in Pregnancy CDC Statement: Pregnancy & Breastfeeding: Information about Coronavirus Disease 2019 (USA) Updated SOGC Committee Opinion – COVID-19 in Pregnancy (Canada) RCOG Statement: Coronavirus (COVID-19) infection and pregnancy (UK) Abortion care: UK...
CATIE (Canada), 17 March 2020 An HIV-positive person on effective treatment is not expected to be at higher risk of becoming seriously ill with COVID-19 A person with untreated HIV or a low CD4+ cell count may be at higher risk of becoming seriously ill with COVID-19 People with HIV or hepatitis C are more likely to have other conditions that carry a greater risk of becoming seriously ill with...
The Conversation, March 4, 2020 10.58pm AEDT Why do so many Asian Americans and Pacific Islander women know so little about HPV? We set out to answer this question by interviewing ethnic groups and conducting surveys. Our findings suggest their knowledge and attitudes toward HPV prevention are closely tied to health beliefs and cultural or language barriers. What’s more, we discovered preventive...
Australian Institute of Health and Welfare, Release Date: 02 Sep 2019 This is the third report from an Australian-first project, combining screening, cancer, death, and HPV vaccination data to demonstrate the effects of screening and HPV vaccination on cervical cancer, precancerous abnormalities and cervical screening behaviour. Screen-detected cervical cancers were less likely to cause death...
RACGP News, 20 Feb 2019 The Lancet Oncology modelling study found 149 of 181 countries could cut rates of the preventable cancer to four per 100,000 women by the end of the century – the threshold for considering it eliminated as a public health problem. The study finds that combining high uptake of the vaccine with high screening could prevent up to 13.4 million cases of cervical cancer within...